May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Elevated TNF- and Soluble TNF Receptor in Degeneration Susceptible Mice with Experimental Coronavirus Retinopathy
Author Affiliations & Notes
  • L.C. Hooper
    Laboratory of Immunology, National Eye Institute, NIH, Bethesda, MD, United States
  • M.S. Chin
    Laboratory of Immunology, National Eye Institute, NIH, Bethesda, MD, United States
  • Y. Wang
    Department of Microbiology and Immunology, Georgetown University Medical Center, Rockville, MD, United States
  • B. Detrick
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States
  • J.J. Hooks
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, United States
  • Footnotes
    Commercial Relationships  L.C. Hooper, None; M.S. Chin, None; Y. Wang, None; B. Detrick, None; J.J. Hooks, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4597. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.C. Hooper, M.S. Chin, Y. Wang, B. Detrick, J.J. Hooks; Elevated TNF- and Soluble TNF Receptor in Degeneration Susceptible Mice with Experimental Coronavirus Retinopathy . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4597.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Experimental coronavirus retinopathy (ECOR) is a retinal degeneration model system that is triggered by a virus and is composed of a genetic and autoimmune component. Increasing evidence suggests that TNF family members play a crucial role in immune-mediated disease processes. Therefore, we compared the levels of TNF-α and soluble TNF-α receptors (sTNFRs) in BALB/c (retinal degeneration susceptible) and CD-1 (retinal degeneration resistant) mice after viral infection. Methods: Mice were injected intravitreally with 5 µl of media (mock-injected) or media with MHV, strain JHM, at a concentration of approximately 1.35 x 106 pfu/ml (virus-injected). Eyes and serum were collected at various time points after inoculation. Eyes were dissected and retinas removed for mRNA isolation followed by RT-PCR for TNF-α. Serum was assayed for the presence of TNF-α and TNF-α receptors by ELISA. Results: During the acute phase of infection (day 4) TNF-α mRNA was detected at higher levels within the retinas of degeneration susceptible BALB/c mice than in non-susceptible CD-1 mice. The serum concentration of TNF-α protein was significantly increased in virus-injected (p<0.005) compared to mock-injected BALB/c mice. In contrast, serum concentrations of TNF-α were not significantly different between virus-injected and mock-injected CD-1 mice. Moreover, sera from 100% of infected BALB/c mice contained TNF-α protein compared to just 25% of the CD-1 mice. In virus-injected BALB/c mice, serum concentrations of sTNFR1 were also elevated significantly compared to mock-injected mice (p< 0.0005). In virus-injected CD-1 mice sTNFR1 was not elevated. While concentrations of sTNFR2 were elevated in both BALB/c (p< 0.00005) and CD-1 (p< 0.005) infected mice compared to their mock-injected controls early in infection (day 4), concentrations of sTNFR2 were significantly higher in infected BALB/c as compared to CD-1 mice (p< 0.0005). Conclusions: These studies demonstrate that TNF-α and sTNFRs are elevated in virus-infected retinal degeneration susceptible BALB/c mice and that these molecules may participate in retinal degenerative processes.

Keywords: cytokines/chemokines • retina • autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×